PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1579749
PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1579749
Biliary Stents
Global Biliary Stents Market to Reach US$797.8 Million by 2030
The global market for Biliary Stents estimated at US$613.6 Million in the year 2023, is expected to reach US$797.8 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Ambulatory Surgery Centers End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$369.0 Million by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 4.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$166.0 Million While China is Forecast to Grow at 6.3% CAGR
The Biliary Stents market in the U.S. is estimated at US$166.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$162.4 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
Global Biliary Stents Market - Key Trends and Drivers Summarized
What Are Biliary Stents and Why Are They Used?
Biliary stents are small, tubular devices inserted into the bile duct to maintain its patency and ensure the proper flow of bile from the liver to the intestine. These stents are primarily used in the treatment of bile duct obstructions caused by conditions such as cholangiocarcinoma (bile duct cancer), pancreatic cancer, gallstones, or benign strictures due to scarring and inflammation. Obstruction in the bile duct can lead to serious complications, including jaundice, biliary cirrhosis, and life-threatening infections such as cholangitis. Biliary stents help alleviate these blockages by providing a pathway for bile drainage, reducing symptoms, and preventing complications. The stents are categorized into two major types: plastic and metal. Plastic stents are generally used for short-term management due to their tendency to occlude over time, while self-expanding metallic stents (SEMS) are preferred for longer-term solutions because they provide a larger lumen and resist clogging. Biliary stents can be placed endoscopically or percutaneously depending on the nature of the obstruction, and are considered an essential tool in both palliative care and preoperative interventions to improve patient outcomes and quality of life. With their ability to reduce symptoms and improve bile flow, biliary stents have become a cornerstone in the management of malignant and benign biliary diseases.
How Are Technological Advances Making Biliary Stents More Effective?
Recent technological advancements have significantly enhanced the efficacy, durability, and safety of biliary stents, broadening their applications and improving patient outcomes. One of the most noteworthy developments is the advent of covered self-expanding metallic stents (CSEMS), which are designed to prevent tissue ingrowth and migration, common issues with traditional metal stents. These stents are coated with biocompatible materials such as polytetrafluoroethylene (PTFE) or silicone, providing an effective barrier that minimizes tumor overgrowth and prolongs stent patency. The use of anti-migration features, such as flared ends and anchoring mechanisms, has further reduced the risk of stent displacement, a complication that can necessitate repeat interventions. Additionally, the introduction of biodegradable stents, which gradually dissolve over time, offers a promising solution for benign strictures, eliminating the need for stent removal procedures. Another major innovation is the use of drug-eluting stents, which are coated with chemotherapeutic agents or anti-proliferative drugs that release medication locally to inhibit tumor growth or scar tissue formation, thereby extending the functional life of the stent. Improvements in stent delivery systems have also played a crucial role, with newer devices allowing for more precise deployment even in tortuous anatomy. These delivery systems are now equipped with enhanced pushability, flexibility, and visibility under imaging guidance, enabling gastroenterologists and interventional radiologists to navigate complex bile duct anatomy with greater ease. Such technological advancements are not only improving the effectiveness and safety profile of biliary stents but are also expanding their role in the management of both malignant and benign biliary conditions.
How Are Shifting Treatment Paradigms and Patient Demographics Shaping the Biliary Stent Market?
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Biliary Stents - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
III. MARKET ANALYSIS
IV. COMPETITION
